Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
74,097
-
Share change
-
-4,346,679
-
Total reported value
-
$26,064
-
Price per share
-
$0.36
-
Number of holders
-
8
-
Value change
-
-$1,579,450
-
Number of buys
-
2
-
Number of sells
-
26
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2023
As of 30 Jun 2023,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
74,097 shares.
The largest 8 holders included
SlateStone Wealth, LLC, KLCM Advisors, Inc., HUNTINGTON NATIONAL BANK, OGOREK ANTHONY JOSEPH /NY/ /ADV, AlphaMark Advisors, LLC, Russell Investments Group, Ltd., TRUST CO OF VERMONT, and CONCOURSE FINANCIAL GROUP SECURITIES, INC..
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.